Table 1 Correlation of clinical factors with HRV in gastric cancer
From: Low heart rate variability relates to the progression of gastric cancer
SDNN (ms) | P value | RMSSD (ms) | P value | |
|---|---|---|---|---|
Sex | 0.507 | 0.052 | ||
Male (n = 274) | 19.30 ± 13.48 | 22.74 ± 19.04 | ||
Female (n = 109) | 18.28 ± 13.85 | 18.88 ± 12.78 | ||
Age (years) | 0.177 | 0.298 | ||
< 65 (n = 229) | 19.78 ± 14.17 | 22.41 ± 17.59 | ||
≥ 65 (n = 154) | 17.87 ± 12.59 | 20.50 ± 17.51 | ||
Borrmann type | 0.008 | 0.013 | ||
I and II (n = 44) | 24.14 ± 18.89 | 27.84 ± 28.47 | ||
III and V (n = 339) | 18.34 ± 12.61 | 20.83 ± 15.49 | ||
Tumor location | 0.436 | 0.364 | ||
Cardia (n = 37) | 20.90 ± 17.64 | 24.82 ± 27.83 | ||
Body (n = 115) | 19.01 ± 11.84 | 21.48 ± 13.88 | ||
Antrum (n = 229) | 18.82 ± 13.68 | 21.35 ± 17.14 | ||
Diffuse (n = 2) | 5.54 ± 3.37 | 4.48 ± 0.31 | ||
Tumor size | 0.001 | 0.002 | ||
≤ 2 cm (n = 30) | 27.47 ± 16.40 | 32.29 ± 20.99 | ||
2–5 cm (n = 229) | 18.65 ± 14.40 | 0.502a | 20.95 ± 19.13 | 0.771a |
> 5 cm (n = 124) | 17.63 ± 10.23 | 20.33 ± 12.06 |